Inhibition of recombinant human cardiac L-type Ca 2+ channel 1C subunits by 3-isobutyl-1-methylxanthine

Author： Fearon I.M. Palmer A.C.V. Balmforth A.J. Ball S.G. Mikala G. Peers C.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.342, Iss.2, 1998-01, pp. : 353-358

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Levosimendan increases L-type Ca 2+ current via phosphodiesterase-3 inhibition in human cardiac myocytes

By Ajiro Y. Hagiwara N. Katsube Y. Sperelakis N. Kasanuki H.

European Journal of Pharmacology, Vol. 435, Iss. 1, 2002-01 ,pp. : 27-33

Elsevier

Access to resources Recommend Favorite

Reduced verapamil inhibition of endothelin-1-constricted rabbit basilar artery due to enhanced non L-type Ca 2+ -channel-dependent constriction

By Zuccarello M. Lee

General Pharmacology, Vol. 35, Iss. 1, 2001-07 ,pp. : 11-15

Elsevier

Access to resources Recommend Favorite

A novel benzothiazine Ca 2+ channel antagonist, semotiadil, inhibits cardiac L-type Ca 2+ currents

By Koidl B. Miyawaki N. Tritthart H.A.

European Journal of Pharmacology, Vol. 322, Iss. 2, 1997-03 ,pp. : 243-247

Elsevier

Access to resources Recommend Favorite

The binding interactions of Ro 40-5967 at the L-type Ca 2+ channel in cardiac tissue

By Rutledge A. Triggle D.J.

European Journal of Pharmacology, Vol. 280, Iss. 2, 1995-07 ,pp. : 155-158

Elsevier

Access to resources Recommend Favorite

Inhibition by antipsychotic drugs of L-type Ca 2+ channel current in PC12 cells

By Ito K. Nakazawa K. Koizumi S. Min L. Takeuchi K. Hashimoto T. Ohno Y. Inoue K.

European Journal of Pharmacology, Vol. 314, Iss. 1, 1996-10 ,pp. : 143-150

Elsevier

Access to resources Recommend Favorite